These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

396 related items for PubMed ID: 16825342

  • 1. Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
    Robben JH, Knoers NV, Deen PM.
    Am J Physiol Renal Physiol; 2006 Aug; 291(2):F257-70. PubMed ID: 16825342
    [Abstract] [Full Text] [Related]

  • 2. Aquaporin 2 mutations in nephrogenic diabetes insipidus.
    Loonen AJ, Knoers NV, van Os CH, Deen PM.
    Semin Nephrol; 2008 May; 28(3):252-65. PubMed ID: 18519086
    [Abstract] [Full Text] [Related]

  • 3. V2R mutations and nephrogenic diabetes insipidus.
    Bichet DG.
    Prog Mol Biol Transl Sci; 2009 May; 89():15-29. PubMed ID: 20374732
    [Abstract] [Full Text] [Related]

  • 4. Nephrogenic diabetes insipidus.
    Bichet DG.
    Adv Chronic Kidney Dis; 2006 Apr; 13(2):96-104. PubMed ID: 16580609
    [Abstract] [Full Text] [Related]

  • 5. Physiopathology and diagnosis of nephrogenic diabetes insipidus.
    Devuyst O.
    Ann Endocrinol (Paris); 2012 Apr; 73(2):128-9. PubMed ID: 22503803
    [Abstract] [Full Text] [Related]

  • 6. Congenital nephrogenic diabetes insipidus: what can we learn from mouse models?
    Boone M, Deen PM.
    Exp Physiol; 2009 Feb; 94(2):186-90. PubMed ID: 18790812
    [Abstract] [Full Text] [Related]

  • 7. Nephrogenic diabetes insipidus.
    Knoers NV, Monnens LL.
    Semin Nephrol; 1999 Jul; 19(4):344-52. PubMed ID: 10435672
    [Abstract] [Full Text] [Related]

  • 8. Molecular and cellular defects in nephrogenic diabetes insipidus.
    Knoers NV, Deen PM.
    Pediatr Nephrol; 2001 Dec; 16(12):1146-52. PubMed ID: 11793119
    [Abstract] [Full Text] [Related]

  • 9. Molecular pathogenesis of nephrogenic diabetes insipidus.
    Nguyen MK, Nielsen S, Kurtz I.
    Clin Exp Nephrol; 2003 Mar; 7(1):9-17. PubMed ID: 14586738
    [Abstract] [Full Text] [Related]

  • 10. [Nephrogenic diabetes insipidus].
    Ishikawa S.
    Nihon Rinsho; 1996 Mar; 54(3):819-24. PubMed ID: 8904243
    [Abstract] [Full Text] [Related]

  • 11. Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus.
    Los EL, Deen PM, Robben JH.
    J Neuroendocrinol; 2010 May; 22(5):393-9. PubMed ID: 20163515
    [Abstract] [Full Text] [Related]

  • 12. Genetic forms of nephrogenic diabetes insipidus (NDI): Vasopressin receptor defect (X-linked) and aquaporin defect (autosomal recessive and dominant).
    Bichet DG, Bockenhauer D.
    Best Pract Res Clin Endocrinol Metab; 2016 Mar; 30(2):263-76. PubMed ID: 27156763
    [Abstract] [Full Text] [Related]

  • 13. [Nephrogenic diabetes insipidus].
    Evrard A, Lefebvre J, Vantyghem M.
    Ann Endocrinol (Paris); 1999 Dec; 60(6):457-64. PubMed ID: 10617799
    [Abstract] [Full Text] [Related]

  • 14. Methyl-beta-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat kidney.
    Russo LM, McKee M, Brown D.
    Am J Physiol Renal Physiol; 2006 Jul; 291(1):F246-53. PubMed ID: 16449354
    [Abstract] [Full Text] [Related]

  • 15. A novel mechanism in recessive nephrogenic diabetes insipidus: wild-type aquaporin-2 rescues the apical membrane expression of intracellularly retained AQP2-P262L.
    de Mattia F, Savelkoul PJ, Bichet DG, Kamsteeg EJ, Konings IB, Marr N, Arthus MF, Lonergan M, van Os CH, van der Sluijs P, Robertson G, Deen PM.
    Hum Mol Genet; 2004 Dec 15; 13(24):3045-56. PubMed ID: 15509592
    [Abstract] [Full Text] [Related]

  • 16. [From genes to disease: from vasopressin-V2-receptor and aquaporine-2 to nephrogenic diabetes insipidus].
    Knoers NV, Deen PM.
    Ned Tijdschr Geneeskd; 2000 Dec 09; 144(50):2402-4. PubMed ID: 11145096
    [Abstract] [Full Text] [Related]

  • 17. Hereditary Nephrogenic Diabetes Insipidus: Pathophysiology and Possible Treatment. An Update.
    Milano S, Carmosino M, Gerbino A, Svelto M, Procino G.
    Int J Mol Sci; 2017 Nov 10; 18(11):. PubMed ID: 29125546
    [Abstract] [Full Text] [Related]

  • 18. Vasopressin type-2 receptor and aquaporin-2 water channel mutants in nephrogenic diabetes insipidus.
    Deen PM, Knoers NV.
    Am J Med Sci; 1998 Nov 10; 316(5):300-9. PubMed ID: 9822112
    [Abstract] [Full Text] [Related]

  • 19. [Pathological aspects of water transport in the collecting ducts].
    Bichet DG.
    Nephrologie; 1996 Nov 10; 17(7):417-22. PubMed ID: 9019668
    [Abstract] [Full Text] [Related]

  • 20. p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation.
    Savelkoul PJ, De Mattia F, Li Y, Kamsteeg EJ, Konings IB, van der Sluijs P, Deen PM.
    Hum Mutat; 2009 Oct 10; 30(10):E891-903. PubMed ID: 19585583
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.